Metabolism, genotoxicity, annd carcinogenicity of comfrey

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 13, Issue 7-8, 2010, Pages 509-526

  Mei, Nan ^a   Guo, Lei ^b   Fu, Peter P ^b   Fuscoe, James C ^a   Luan, Yang ^c   Chen, Tao ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b Division of Biochemical Toxicology   (United States)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DIHYDRO 7 HYDROXY 1 HYDROXYMETHYL 5H PYRROLIZINE; 7 ACETYLLYCOPSAMINE; ACETYLINTERMEDIN; CARCINOGEN; COMFREY EXTRACT; ECHIMIDINE; INTERMEDINE; LASIOCARPINE; LYCOPSAMINE; MUTAGENIC AGENT; MYOSCORPINE; PYRROLIZIDINE ALKALOID; PYRROLIZINE DERIVATIVE; SYMLANDINE; SYMPHYTINE; SYMVIRIDINE; UNCLASSIFIED DRUG; PLANT MEDICINAL PRODUCT;

ARTICLE; CARCINOGENESIS; CARCINOGENICITY; COMFREY; DNA DAMAGE; ENDOTHELIUM CELL; GENOTOXICITY; HUMAN; LIVER CELL; MUTAGENESIS; NONHUMAN; ANIMAL; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; LIVER; METABOLISM; RAT;

ANIMALIA; RODENTIA; SYMPHYTUM;

ANIMALS; CARCINOGENS; COMFREY; HUMANS; LIVER; MUTAGENS; PLANT PREPARATIONS; PYRROLIZIDINE ALKALOIDS; RATS;

EID: 78650478663     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937404.2010.509013     Document Type: Article

References (88)

1. Abbott, P. J. 1988. Comfrey: Assessing the low-dose health risk. Med. J. Aust. 149:678-682.
2. Altamirano, J.C., Gratz, S.R., and Wolnik, K.A. 2005. Investigation of pyrrolizidine alkaloids and their N-oxides in commercial comfrey-containing products and botanical materials by liquid chromatography electrospray ion-ization mass spectrometry. J. Am. Off. Assoc. Chem. Int. 88:406-412.
3. Bach, N., Thung, S. N., and Schaffner, F. 1989. Comfrey herb tea-induced hepatic veno-occlusive disease. Am. J. Med. 87:97-99.
4. Behninger, C., Abel, G., Roder, E., Neuberger, V., and Goggelmann, W. 1989. [Studies on the effect of an alkaloid extract of Symphytum officinale on human lymphocyte cultures]. Planta Med. 55:518-522.
5. Betz, J. M., Eppley, R. M., Taylor, W. C., and Andrzejewski, D. 1994. Determination of pyrrolizidine alkaloids in commercial com-frey products (Symphytum sp.). J. Pharm. Sci. 83:649-653.
6. Bleakley, C. M., McDonough, S. M., and MacAuley, D. C. 2008. Some conservative strategies are effective when added to controlled mobilisation with external support after acute ankle sprain: A systematic review. Aust. J. Physiother. 54:7-20.
7. Brauchli, J., Luthy, J., Zweifel, U., and Schlatter, C. 1982. Pyrrolizidine alkaloids from Symphytum officinale L. and their percutaneous absorption in rats. Experientia 38:1085-1087.
8. Chen, T., Mei, N., and Fu, P. P. 2010. Genotoxicity of pyrrolizidine alkaloids. J. Appl. Toxicol. 30:183-196.
9. Chou, M. W., and Fu, P. P. 2006. Formation of DHP-derived DNA adducts in vivo from dietary supplements and Chinese herbal plant extracts containing carcinogenic pyrrolizidine alkaloids. Toxicol. Ind. Health 22:321-327.
10. Chou, M. W., Jian, Y., Williams, L. D., Xia, Q., Churchwell, M., Doerge, D. R., and Fu, P. P. 2003a. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid. Chem. Res. Toxicol. 16:1130-1137.
11. Chou, M. W., Wang, Y. P., Yan, J., Yang, Y. C., Beger, R. D., Williams, L. D., Doerge, D. R., and Fu, P. P. 2003b. Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine. Toxicol. Lett. 145:239-247.
12. Chou, M. W., Yan, J., Nichols, J., Xia, Q., Beland, F. A., Chan, P. C., and Fu, P. P. 2003c. Correlation of DNA adduct formation and riddelliine-induced liver tumorigen-esis in F344 rats and B6C3F(1) mice. Cancer Lett. 193:119-125.
13. Couet, C. E., Crews, C., and Hanley, A. B. 1996. Analysis, separation, and bioassay of pyrrolizidine alkaloids from com-frey (Symphytum officinale). Nat. Toxins 4:163-167.
14. Crews, C., Startin, J. R., and Clarke, P. A. 1997. Determination of pyrrolizidine alkaloids in honey from selected sites by solid phase extraction and HPLC-MS. Food Addit. Contam. 4:419-428.
15. Deinzer, M. L., Thomson, P. A., Burgett, D. M., and Isaacson, D. L. 1977. Pyrrolizidine alkaloids: Their occurrence in honey from tansy ragwort (Senecio jacobaea L.). Science 195:497-499.
16. DeLeve, L. D., Shulman, H. M., and McDonald, G. B. 2002. Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease). Semin. Liver Dis. 22:27-42.
17. Dueker, S. R., Lame, M. W., Morin, D., Wilson, D. W., and Segall, H. J. 1992. Guinea pig and rat hepatic microsomal metabolism of monocrotaline. Drug Metab. Dispos. 20:275-280.
18. Edgar, J. A., Roeder, E., and Molyneux, R. J. 2002. Honey from plants containing pyrrolizidine alkaloids: A potential threat to health. J. Agric. Food Chem. 50:2719-2730.
19. Food and Drug Administration. 2001. FDA advises dietary supplement manufacturers to remove comfrey products from the market. USFDA, Center for Food Safety and Applied Nutrition. http://www. fda.gov/Food/DietarySupplements/ Alerts/ucm 111219.htm
20. Frei, H., Luthy, J., Brauchli, J., Zweifel, U., Wurgler, F. E., and Schlatter, C. 1992. Structure/activity relationships of the geno-toxic potencies of sixteen pyrrolizidine alkaloids assayed for the induction of somatic mutation and recombination in wing cells of Drosophila melanogaster. Chem. Biol. Interact. 83:1-22.
21. Fu, P. P., Chou, M. W., Xia, Q., Yang, Y. C., Yan, J., Doerge, D. R., and Chan, P. C. 2001. Genotoxic pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides- Mechanisms leading to DNA adduct formation and tumorigenicity. J. Environ. Sci. Health C Environ. Carcinogen. Ecotoxicol. Rev. 19:353-386.
22. Fu, P. P., Xia, Q., Lin, G., and Chou, M. W. 2004. Pyrrolizidine alkaloids-Genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab. Rev. 36:1-55.
23. Fu, P. P., Xia, Q., Chou, M. W., and Lin, G. 2007. Detection, hepatotoxicity, and tumorigenicity of pyrrolizidine alkaloids in Chinese herbal plants and herbal dietary supplements. J. Food Drug Anal. 15:400-415.
24. Fuhr, U. 2000. Induction of drug metabolising enzymes: Pharmacokinetic and toxi-cological consequences in humans. Clin. Pharmacokinet. 38:493-504.
25. Furmanowa, M., Guzewska, J., and Beldowska, B. 1983. Mutagenic effects of aqueous extracts of Symphytum officinale L. and of its alkaloidal fractions. J. Appl. Toxicol. 3:127-130.
26. Furuya, T., and Araki, K. 1968. Studies on constituents of crude drugs. I. Alkaloids of Symphytum officinale Linn. Chem. Pharm. Bull (Tokyo) 16:2512-2516.
27. Garrett, B. J., Cheeke, P. R., Miranda, C. L., Goeger, D. E., and Buhler, D. R. 1982. Consumption of poisonous plants (Senecio jacobaea, Symphytum officinale, Pteridium aquilinum, Hypericum perforatum) by rats: Chronic toxicity, mineral metabolism, and hepatic drug-metabolizing enzymes. Toxicol. Lett. 10:183-188.
28. Gomes, M. F., de Oliveira Massoco, C., Xavier, J. G., and Bonamin, L. V. 2007. Comfrey (Symphytum Officinale. L.) and experimental hepatic carcinogenesis: A short-term carcinogenesis model study. Evidence Based Complement. Altern. Med. doi: 10.1093/ecam/nem172.
29. Gray, D. E., Porter, A., O'Neill, T., Harris, R. K., and Rottinghaus, G. E. 2004. A rapid cleanup method for the isolation and concentration of pyrrolizidine alkaloids in comfrey root. J. Am.Off. Assoc. Chem. Int. 87:1049-1057.
30. Guo, L., Lobenhofer, E. K., Wang, C., Shippy, R., Harris, S. C., Zhang, L., Mei, N., Chen, T., Herman, D., Goodsaid, F. M., Hurban, P., Phillips, K. L., Xu, J., Deng, X., Sun, Y. A., Tong, W., Dragan, Y. P., and Shi, L. 2006. Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat. Biotechnol. 24:1162-1169.
31. Guo, L., Mei, N., Dial, S., Fuscoe, J., and Chen, T. 2007. Comparison of gene expression profiles altered by comfrey and riddelliine in rat liver. BMC Bioinformatics 8(suppl. 7):S22.
32. Gyorik, S., and Stricker, H. 2009. Severe pulmonary hypertension possibly due to pyrrolizidine alkaloids in polyphytotherapy. Swiss. Med. Weekly 139:210-211.
33. Haworth, S., Lawlor, T., Mortelmans, K., Speck, W., and Zeiger, E. 1983. Salmonella muta-genicity test results for 250 chemicals. Environ. Mutagen. 5(suppl. 1):1-142.
34. Hirono, I., Haga, M., Fujii, M., Matsuura, S., Matsubara, N., Nakayama, M., Furuya, T., Hikichi, M., Takanashi, H., Uchida, E., Hosaka, S., and Ueno, I. 1979. Induction of hepatic tumors in rats by senkirkine and symphytine. JNCI 63:469-472.
35. Hirono, I., Mori, H., and Haga, M. 1978. Carcinogenic activity of Symphytum offici-nale. JNCI 61:865-869.
36. Huxtable, R. J., Luthy, J., and Zweifel, U. 1986. Toxicity of comfrey-pepsin preparations. N. Engl. J. Med. 315:1095.
37. Integrated Laboratory Systems. 1997. Comfrey and one of its constituent alkaloids sym-phytine. http://ntpniehsnihgov/ntp/htdocs/ Chem-Background/ ExSumPdf/Comfreypdf
38. International Programme on Chemical Safety. 1989. Pyrrolizidine alkaloids health and safety guide. Health and Safety Criteria Guide 26. Geneva, Switzerland: WHO.
39. Kim, N. C., Oberlies, N. H., Brine, D. R., Handy, R. W., Wani, M. C., and Wall, M. E. 2001. Isolation of symlandine from the roots of common comfrey (Symphytum offic-inale) using countercurrent chromatography. J. Nat. Prod. 64:251-253.
40. Koll, R., Buhr, M., Dieter, R., Pabst, H., Predel, H. G., Petrowicz, O., Giannetti, B., Klingenburg, S., and Staiger, C. 2004. Efficacy and tolerance of a comfrey root extract (Extr. Rad. Symphyti) in the treatment of ankle distorsions: Results of a multicenter, randomized, placebo-controlled, double-blind study. Phytomedicine 11:470-477.
41. Lame, M. W., Morin, D., Jones, A.D., Segall, H. J., and Wilson, D. W. 1990. Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline. Toxicol. Lett. 51:321-329.
42. Lame, M. W., Jones, A. D., Morin, D., and Segall, H. J. 1991. Metabolism of [14C]monocrotaline by isolated perfused rat liver. Drug Metab. Dispos. 19:516-524.
43. Lin, G., Cui, Y. Y., and Hawes, E. M. 2000. Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid. Drug Metab. Dispos. 28:1475-1483.
44. Lin, G., Cui, Y. Y., Liu, X. Q., and Wang, Z. T. 2002. Species differences in the in vitro metabolic activation of the hepatotoxic pyrrolizidine alkaloid clivorine. Chem. Res. Toxicol. 15:1421-1428.
45. Lin, G., Nnane, I. P., and Cheng, T. Y. 1999. The effects of pretreatment with glycyrrhizin and glycyrrhetinic acid on the retrorsine-induced hepatotoxicity in rats. Toxicon 37:1259-1270.
46. Lin, G., Zhou, K. Y., Zhao, X. G., Wang, Z. T., and But, P. P. 1998. Determination of hep-atotoxic pyrrolizidine alkaloids by on-line high performance liquid chromatography mass spectrometry with an electrospray interface. Rapid Commun. Mass. Spectrom. 12:1445-1456.
47. Liu, F., Wan, S. Y., Jiang, Z., Li, S. F., Ong, E. S., and Osorio, J. C. 2009. Determination of pyrrolizidine alkaloids in comfrey by liquid chromatography-electrospray ionization mass spectrometry. Talanta 80:916-923.
48. Martignoni, M., Groothuis, G. M., and de Kanter, R. 2006. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert. Opin. Drug Metab. Toxicol. 2:875-894.
49. Mattocks, A. R. 1967. Detection of pyrroli-zidine alkaloids on thin-layer chromato-grams. J. Chromatogr. 27:505-508.
50. Mattocks, A. R. 1986. Chemistry and toxicology of pyrrolizidine alkaloids. New York: Academic Press.
51. Mei, N., Guo, L., Fu, P. P., Heflich, R. H., and Chen, T. 2005. Mutagenicity of com-frey (Symphytum officinale) in rat liver. Br. J. Cancer 92:873-875.
52. Mei, N., Guo, L., Zhang, L., Shi, L., Sun, Y.A., Fung, C., Moland, C. L., Dial, S. L., Fuscoe, J. C., and Chen, T. 2006. Analysis of gene expression changes in relation to toxicity and tumorigenesis in the livers of Big Blue trans-genic rats fed comfrey (Symphytum offici-nale). BMC Bioinformatics 7(suppl. 2):S16.
53. Mei, N., Heflich, R. H., Chou, M. W., and Chen, T. 2004. Mutations induced by the carcinogenic pyrrolizidine alkaloid riddelli-ine in the liver cII gene of transgenic Big Blue rats. Chem. Res. Toxicol. 17:814-818.
54. Mei, X., and Chen, T. 2007. The mutant frequency and types of mutations induced by comfrey in the lungs of transgenic Big Blue rats. J. Food Drug Anal. 15:458-465.
55. National Toxicology Program. 1978. Bioassay of lasiocarpine for possible carcinogenicity (CAS No. 303-34-4). http:// ntpniehsnihgov/?objectid=07032341- E34A-AFA1-C61487B8222FC5A8
56. National Toxicology Program. 2008. Report on carcinogen. Fed. Reg. 73:23463-23465, http://ntp.niehs.nih.gov/files/23473-FR-234 84-23430Apr22008- 23508.pdf
57. Oberlies, N. H., Kim, N. C., Brine, D. R., Collins, B. J., Handy, R. W., Sparacino, C. M., Wani, M. C., and Wall, M. E. 2004. Analysis of herbal teas made from the leaves of comfrey (Symphytum officinale): reduction of N-oxides results in order of magnitude increases in the measurable concentration of pyrrolizidine alkaloids. Public Health Nutr. 7:919-924.
58. Prakash, A. S., Pereira, T. N., Reilly, P. E., and Seawright, A. A. 1999. Pyrrolizidine alkaloids in human diet. Mutat. Res. 443:53-67.
59. Rao, M. S., and Reddy, J. K. 1978. Malignant neoplasms in rats fed lasiocarpine. Br. J. Cancer 37:289-293.
60. 14C-monocrotaline in rat liver microsomes. J. Biochem. Mol. Toxicol. 12:157-166.
61. Ridker, P. M., and McDermott, W. V. 1989. Comfrey herb tea and hepatic veno-occlusive disease. Lancet 8639:657-658.
62. Ridker, P. M., Ohkuma, S., McDermott, W. V., Trey, C., and Huxtable, R. J. 1985. Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology 88:1050-1054.
63. Ridker, P. N., and McDermont, W. V. 1989. Hepatotoxicity due to comfrey herb tea. Am. J. Med. 87:701.
64. Rode, D. 2002. Comfrey toxicity revisited. Trends Pharmacol. Sci. 23:497-499.
65. Roeder, E. 1995. Medicinal plants in Europe containing pyrrolizidine alkaloids. Pharmazie 50:83-98.
66. Roitman, J. N. 1981. Comfrey and liver damage. Lancet 8226:944.
67. Sakakura, C. E., Neto, R. S., Bellucci, M., Wenzel, A., Scaf, G., and Marcantonio, E., Jr. 2008. Influence of homeopathic treatment with comfrey on bone density around titanium implants: a digital subtraction radiography study in rats. Clin. Oral Implants Res. 19:624-628.
68. Schaneberg, B. T., Molyneux, R. J., and Khan, I. A. 2004. Evaporative light scattering detection of pyrrolizidine alkaloids. Phytochem. Anal. 15:36-39.
69. Schoental, R., Fowler, M. E., and Coady, A. 1970. Islet cell tumors of the pancreas found in rats given pyrrolizidine alkaloids from Amsinckia intermedia Fisch and Mey and from Heliotropium supinum L. Cancer Res. 30:2127-2131.
70. Snider, S. 1991. Herbal teas and toxicity. FDA Consumer 25:30-33.
71. Stickel, F., and Seitz, H. K. 2000. The efficacy and safety of comfrey. Public Health Nutr. 3:501-508.
72. Svoboda, D. J., and Reddy, J. K. 1972. Malignant tumors in rats given lasiocarpine. Cancer Res. 32:908-913.
73. Takanashi, H., Umeda, M., and Hirono, I. 1980. Chromosomal aberrations and mutation in cultured mammalian cells induced by pyrrolizidine alkaloids. Mutat. Res. 78:67-77.
74. Vollmer, J. J., Steiner, N. C., Larsen, G. Y., Muirhead, K. M., and Molyneux, R. J. 1987. Pyrrolizidine alkaloids: testing for toxic constituents of comfrey. J. Chem. Educ. 64:1027-1030.
75. Weston, C. F., Cooper, B. T., Davies, J. D., and Levine, D. F. 1987. Veno-occlusive disease of the liver secondary to ingestion of comfrey. Br. Med. J. (Clin. Res. Ed.) 295:183.
76. White, R. D., Krumperman, P. H., Cheeke, P. R., and Buhler, D. R. 1983. An evaluation of acetone extracts from six plants in the Ames mutagenicity test. Toxicol. Lett. 15:25-31.
77. Willett, K. L., Roth, R. A., and Walker, L. 2004. Workshop overview: Hepatotoxicity assessment for botanical dietary supplements. Toxicol. Sci. 79:4-9.
78. Williams, D. E., Reed, R. L., Kedzierski, B., Ziegler, D. M., and Buhler, D. R. 1989. The role of flavin-containing monooxyge-nase in the N-oxidation of the pyrrolizidine alkaloid senecionine. Drug Metab. Dispos. 17:380-386.
79. Winship, K. A. 1991. Toxicity of comfrey. Adverse Drug React. Toxicol. Rev. 10:47-59.
80. Wuilloud, J. C., Gratze, S. R., Gamble, B. M., and Wolnik, K. A. 2004. Simultaneous analysis of hepatotoxic pyrrolizidine alkaloids and N-oxides in comfrey root by LC-ion trap mass spectrometry. Analyst 129:150-156.
81. Xia, Q., Chou, M. W., Edgar, J. A., Doerge, D. R., and Fu, P. P. 2006. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine. Cancer Lett. 231:138-145.
82. Yamanaka, H., Nagao, M., Sugimura, T., Furuya, T., Shirai, A., and Matsushima, T. 1979. Mutagenicity of pyrrolizidine alkaloids in the Salmonella/mammalian-microsome test. Mutat. Res. 68:211-216.
83. Yan, C. C., and Huxtable, R. J. 1996. Effects of monocrotaline, a pyrrolizidine alkaloid, on glutathione metabolism in the rat. Biochem. Pharmacol. 51:375-379.
84. Yang, Y. C., Yan, J., Doerge, D. R., Chan, P. C., Fu, P. P., and Chou, M. W. 2001. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo. Chem. Res. Toxicol. 14:101-109. (Pubitemid 32064380)
85. Yeong, M. L., Clark, S. P., Waring, J. M., Wilson, R. D., and Wakefield, S. J. 1991. The effects of comfrey derived pyrrolizidine alkaloids on rat liver. Pathology 23:35-38.
86. Yeong, M. L., Swinburn, B., Kennedy, M., and Nicholson, G. 1990. Hepatic veno-occlusive disease associated with comfrey ingestion. J. Gastroenterol. Hepatol. 5:211-214.
87. Yoon, J. S., Mason, J. M., Valencia, R., Woodruff, R. C., and Zimmering, S. 1985. Chemical mutagenesis testing in Drosophila. IV. Results of 45 coded compounds tested for the National Toxicology Program. Environ. Mutagen 7:349-367. (Pubitemid 15051953)
88. Zhou, S., Koh, H. L., Gao, Y., Gong, Z. Y., and Lee, E. J. 2004. Herbal bioactivation: The good, the bad and the ugly. Life Sci. 74:935-968.